| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $9,461 | 1 | 100 |
| WILLS STEPHEN T | Executive VP and CFO/COO | 0 | $0 | 1 | $9,461 | $-9,461 |
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company …
Over the last 12 months, insiders at Palatin Technologies, Inc. have bought $0 and sold $9,461 worth of Palatin Technologies, Inc. stock.
On average, over the past 5 years, insiders at Palatin Technologies, Inc. have bought $151.36M and sold $18,274 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,500 shares for transaction amount of $225M was made by SPANA CARL (President and CEO) on 2025‑06‑13.
| 2025-12-24 | Sale | WILLS STEPHEN T | Executive VP and CFO/COO | 565 0.1977% | $16.74 | $9,461 | -11.56% | |
| 2025-06-13 | SPANA CARL | President and CEO | 1,500 – | $150,000.00 | $225M | +189.80% | ||
| 2025-06-13 | WILLS STEPHEN T | Executive VP and CFO/COO | 1,500 – | $150,000.00 | $225M | +189.80% | ||
| 2025-06-13 | DUNTON ALAN W | director | 200 – | $20,000.00 | $4M | +189.80% | ||
| 2025-05-07 | DEVEER ROBERT K JR | director | 100,000 0.2127% | $0.10 | $10,180 | +144.44% | ||
| 2024-08-01 | Sale | WILLS STEPHEN T | Executive VP and CFO/COO | 4,999 0.0253% | $1.66 | $8,274 | -47.93% | |
| 2024-04-11 | DEVEER ROBERT K JR | director | 6,000 0.0394% | $2.12 | $12,703 | -40.50% | ||
| 2024-03-06 | Sale | DEVEER ROBERT K JR | director | 11,700 0.0789% | $2.00 | $23,434 | -23.66% | |
| 2023-12-06 | Sale | WILLS STEPHEN T | Executive VP and CFO/COO | 4,998 0.0341% | $2.51 | $12,563 | -30.93% | |
| 2023-12-04 | Sale | DUNTON ALAN W | director | 200 0.0014% | $2.48 | $496 | -23.94% | |
| 2022-12-27 | SPANA CARL | President and CEO | 10,000 0.093% | $2.23 | $22,297 | +3.60% | ||
| 2022-12-27 | WILLS STEPHEN T | Executive VP and CFO/COO | 10,000 0.0928% | $2.22 | $22,245 | +3.60% | ||
| 2022-12-21 | Sale | DUNTON ALAN W | director | 200 0.002% | $2.97 | $594 | -16.67% | |
| 2021-07-01 | Hull Joseph Stanley | director | 10,000 0.0041% | $0.61 | $6,100 | -30.65% | ||
| 2021-07-01 | Morris Arlene | director | 33,000 0.0139% | $0.62 | $20,460 | -30.65% | ||
| 2021-06-30 | SPANA CARL | President and CEO | 75,000 0.0319% | $0.62 | $46,394 | -29.51% | ||
| 2021-06-30 | WILLS STEPHEN T | Executive VP and CFO/COO | 75,000 0.0318% | $0.62 | $46,238 | -29.51% | ||
| 2021-06-30 | DUNTON ALAN W | director | 20,000 0.0085% | $0.62 | $12,350 | -29.51% | ||
| 2020-11-18 | DEVEER ROBERT K JR | director | 54,000 0.0215% | $0.41 | $22,140 | +25.00% | ||
| 2020-09-29 | Sale | DEVEER ROBERT K JR | director | 54,000 0.0219% | $0.46 | $24,980 | +14.58% |
| WILLS STEPHEN T | Executive VP and CFO/COO | 63488 3.5649% | $331,407.36 | 10 | 3 | <0.0001% |
| Hull Joseph Stanley | director | 775966 43.5706% | $4.05M | 5 | 0 | <0.0001% |
| Morris Arlene | director | 698666 39.2302% | $3.65M | 2 | 0 | <0.0001% |
| SPANA CARL | President and CEO | 293604 16.4859% | $1.53M | 11 | 0 | <0.0001% |
| DUNTON ALAN W | director | 224112 12.5839% | $1.17M | 11 | 3 | +80.15% |
| DEVEER ROBERT K JR | director | 138065 7.7524% | $720,699.30 | 6 | 2 | +42.98% |
| PRENDERGAST JOHN K A | director | 17673 0.9923% | $92,253.06 | 1 | 0 | |
| MOLINOFF PERRY B | director | 11000 0.6177% | $57,420.00 | 1 | 0 | |
| HOROVITZ ZOLA P | director | 10500 0.5896% | $54,810.00 | 1 | 0 | |
| TABER ROBERT I | director | 5500 0.3088% | $28,710.00 | 1 | 0 | |
| Hallam Trevor | Exec. VP - R&D | 2500 0.1404% | $13,050.00 | 1 | 0 |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$76,600 | 22 | -38.58% | $10.49M | |
$812,698 | 12 | -57.09% | $7.89M | |
$4,146,041 | 11 | -40.86% | $8.55M |
| Increased Positions | 22 | +1,100% | 842,840 | +42.14M% |
| Decreased Positions | <1 | -50% | 2 | -100% |
| New Positions | 22 | New | 842,840 | New |
| Sold Out Positions | <1 | Sold Out | 2 | Sold Out |
| Total Postitions | 23 | +1,050% | 842,840 | +42.14M% |